Catabasis, a Cambridge biotech startup, is currently advancing a platform to simultaneously modulate multiple targets in disease pathways. Researchers there…
Articles by Isaura Santos
The Muscular Dystrophy Association (MDA) recently announced that MDA clinics are offering genetic testing for those with limb-girdle muscular dystrophy (LGMD) thanks to…
PhaseBio Pharmaceuticals, Inc., a leading company in biopolymer-based drugs developing treatments to address metabolic and specific cardiopulmonary disorders, recently announced that…
Santhera Pharmaceuticals‘ Principal Investigator Gunnar M. Buyse will be presenting Phase III data on Idebenone (Raxone®/Catena®) for the treatment…
The Stanford Comprehensive Neuromuscular Clinic at Lucile Packard Children’s Hospital (Stanford) was recently named by…
The FSH Society, a charity organization based in Massachusetts supporting research and advocacy related to …
Charles Gersbach, Muscular Dystrophy Association research grantee and Biomedical Engineering Professor at Duke University, has recently announced…
BioBlast Pharma, a clinical-stage biotechnology firm focused on developing orphan disease drugs, recently announced it has received an allowance…
ReveraGen BioPharma recently announced the start of a Phase 1 clinical trial of a new disassociate steroidal drug…
Researchers working in public health have recently published a report based on the first broad study in the United States on…